Catheter malfunction determinations using physiologic pressure
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61M-005/00
A61B-005/08
A61B-005/02
A61M-031/00
출원번호
US-0731356
(2007-03-30)
등록번호
US-8323244
(2012-12-04)
발명자
/ 주소
Miesel, Keith A.
Coffey, Robert J.
출원인 / 주소
Medtronic, Inc.
대리인 / 주소
Mueting Raasch & Gebhardt PA
인용정보
피인용 횟수 :
0인용 특허 :
79
초록▼
Methods and systems for determining whether an implanted catheter used to deliver fluids to a selected internal delivery site is malfunctioning. The malfunctions may include that the infusion section of the catheter is not located at or has migrated away from the selected internal delivery site, is
Methods and systems for determining whether an implanted catheter used to deliver fluids to a selected internal delivery site is malfunctioning. The malfunctions may include that the infusion section of the catheter is not located at or has migrated away from the selected internal delivery site, is leaking, is blocked, etc. The determination is made by analyzing the pressure modulation of fluid within the catheter and determining whether the pressure of the fluid in the catheter is modulated by physiologic pressure changes experienced at the selected internal delivery site. The physiologic pressure modulations at the selected internal delivery site may be caused by, e.g., cardiac activity, respiration, changes in patient's posture, etc.
대표청구항▼
1. A method of identifying the presence of a catheter malfunction in an implanted catheter, the method comprising: measuring pressure of a fluid located within a lumen in a catheter implanted in a patient, wherein the lumen extends to an infusion section that is located at a selected internal delive
1. A method of identifying the presence of a catheter malfunction in an implanted catheter, the method comprising: measuring pressure of a fluid located within a lumen in a catheter implanted in a patient, wherein the lumen extends to an infusion section that is located at a selected internal delivery site in the cerebrospinal fluid of the patient;developing a pressure modulation profile of the cerebrospinal fluid of the patient based on the measured pressure of the fluid in the lumen, wherein developing the pressure modulation profile is based on measuring the pressure of the fluid in the lumen when the fluid is stationary within the lumen;comparing the pressure modulation profile to a selected pressure profile, wherein the selected pressure profile includes a physiological pressure modulation; anddetermining the existence of a catheter malfunction if the pressure modulation profile does not include a feature of the physiological pressure modulation of the selected pressure profile. 2. A method according to claim 1, further comprising providing an alert to the patient and/or a third party after determining the existence of the catheter malfunction. 3. A method according to claim 1, further comprising terminating delivery of the fluid to the lumen after determining the existence of a catheter malfunction. 4. A method according to claim 1, wherein the selected pressure profile is based at least in part on patient respiration. 5. A method according to claim 1, wherein the selected pressure profile is based at least in part on patient cardiac activity. 6. A method according to claim 1, wherein the selected internal delivery site is in the intrathecal space of the patient. 7. A method according to claim 6, wherein the selected pressure profile is based at least in part on changes in the pressure of the fluid as the patient moves between supine and upright postures. 8. A method according to claim 1, wherein the pressure modulation profile is developed based on pressure measurements obtained at only selected intervals. 9. A method according to claim 8, wherein the selected intervals are chosen based at least in part on the patient's circadian rhythm. 10. A method according to claim 1, wherein the fluid in the lumen of the catheter comprises a therapeutic substance, and wherein the method further comprises delivering the therapeutic substance to the patient through the infusion section of the catheter. 11. A method according to claim 1, further comprising storing data representative of the pressure modulation profile in a data storage device before comparing the pressure modulation profile to a selected pressure profile. 12. A method of identifying the presence of a catheter malfunction in an implanted catheter, the method comprising: measuring fluid pressure of a fluid located within a lumen in a catheter implanted in a patient, wherein the lumen extends to an infusion section that is located at a selected internal delivery site in the patient, wherein the selected internal delivery site is in the intrathecal space of the patient;developing a pressure modulation profile based on the measured fluid pressure of the fluid in the lumen;determining if the pressure modulation profile includes pressure modulation caused by patient cardiac activity by determining if the pressure modulation profile comprises a peak corresponding to the patient's cardiac activity; anddetermining that a catheter complication exists if the pressure modulation profile does not include the pressure modulation caused by the patient cardiac activity. 13. A method according to claim 12, wherein developing the pressure modulation profile is based on measuring the pressure of the fluid in the lumen when the fluid is stationary within the lumen. 14. A method according to claim 12, further comprising determining the existence of a catheter malfunction if the pressure modulation profile does not include pressure modulation caused by patient cardiac activity. 15. A method according to claim 14, further comprising providing an alert to the patient and/or a third party after determining the existence of the catheter malfunction. 16. A method according to claim 14, wherein the fluid comprises a therapeutic substance, and wherein the method further comprises: delivering the therapeutic substance to the patient through the infusion section of the catheter; andterminating delivery of the therapeutic substance to the patient after determining the existence of a catheter malfunction. 17. A method according to claim 12, wherein the pressure modulation profile is developed based on pressure measurements obtained at only selected intervals. 18. A method according to claim 17, wherein the selected intervals are chosen based at least in part on the patient's circadian rhythm. 19. A method of identifying the presence of a catheter malfunction in an implanted catheter, the method comprising: measuring fluid pressure of a fluid located within a lumen in a catheter implanted in a patient, wherein the lumen extends to an infusion section that is located at a selected internal delivery site in the patient, wherein the selected internal delivery site is in the intrathecal space of the patient;developing a pressure modulation profile based on the measured fluid pressure of the fluid in the lumen;determining if the pressure modulation profile includes pressure modulation caused by patient respiration by determining if the pressure modulation profile comprises a peak corresponding to the patient's respiratory activity; anddetermining that a catheter complication exists if the pressure modulation profile does not include the pressure modulation caused by the patient respiration. 20. A method according to claim 19, wherein developing the pressure modulation profile is based on measuring the pressure of the fluid in the lumen when the fluid is stationary within the lumen. 21. A method according to claim 19, further comprising determining the existence of a catheter malfunction if the pressure modulation profile does not include pressure modulation caused by patient respiration. 22. A method according to claim 21, further comprising providing an alert to the patient and/or a third party after determining the existence of the catheter malfunction. 23. A method according to claim 21, wherein the fluid comprises a therapeutic substance, and wherein the method further comprises: delivering the therapeutic substance to the patient through the infusion section of the catheter; andterminating delivery of the therapeutic substance to the patient after determining the existence of a catheter malfunction. 24. A method according to claim 19, wherein the pressure modulation profile is developed based on pressure measurements obtained at only selected intervals. 25. A method according to claim 24, wherein the selected intervals are chosen based at least in part on the patient's circadian rhythm. 26. An implantable infusion system comprising: a pump mechanism fluidly coupled to a reservoir to receive fluid contained within the reservoir;a catheter comprising a delivery lumen fluidly coupled to the pump mechanism, wherein the delivery lumen extends to an implantable infusion section in the catheter;a pressure sensor positioned to monitor fluid pressure within the delivery lumen of the catheter and provide a pressure signal representative of the fluid pressure; andcontrol electronics connected to receive the pressure signal from the pressure sensor, wherein the control electronics further: develop a pressure modulation profile based on the fluid pressure measured in the delivery lumen;determine if the pressure modulation profile includes a physiological pressure modulation caused by movement between supine and upright postures; anddetermine that a catheter complication exists if the pressure modulation profile does not include the physiological pressure modulation caused by movement between supine and upright postures. 27. A system according to claim 26, wherein the pump mechanism, the reservoir, and the control electronics are contained within one or more implantable housings along with a power source. 28. An implantable infusion system comprising: a pump mechanism fluidly coupled to a reservoir to receive fluid contained within the reservoir;a catheter comprising a delivery lumen fluidly coupled to the pump mechanism, wherein the delivery lumen extends to an implantable infusion section in the catheter;a pressure sensor positioned to monitor fluid pressure within the delivery lumen of the catheter and provide a pressure signal representative of the fluid pressure; andcontrol electronics connected to receive the pressure signal from the pressure sensor, wherein the control electronics further: develop a pressure modulation profile based on the fluid pressure measured in the delivery lumen;determine if the pressure modulation profile includes a pressure modulation caused by patient cardiac activity by determining if the pressure modulation profile comprises a peak corresponding to the patient's cardiac activity; anddetermine that a catheter complication exists if the pressure modulation profile does not include the peak corresponding to modulations caused by the patient cardiac activity. 29. A system according to claim 28, wherein the pump mechanism, the reservoir, and the control electronics are contained within one or more implantable housings along with a power source. 30. An implantable infusion system comprising: a pump mechanism fluidly coupled to a reservoir to receive fluid contained within the reservoir;a catheter comprising a delivery lumen fluidly coupled to the pump mechanism, wherein the delivery lumen extends to an implantable infusion section in the catheter;a pressure sensor positioned to monitor fluid pressure within the delivery lumen of the catheter and provide a pressure signal representative of the fluid pressure; andcontrol electronics connected to receive the pressure signal from the pressure sensor, wherein the control electronics further: develop a pressure modulation profile based on the fluid pressure measured in the delivery lumen;determine if the pressure modulation profile includes pressure modulation caused by patient respiration by determining if the pressure modulation profile comprises a peak corresponding to the patient's respiratory activity; anddetermine that a catheter complication exists if the pressure modulation profile does not include the peak corresponding to the patient's respiratory activity. 31. A system according to claim 30, wherein the pump mechanism, the reservoir, and the control electronics are contained within one or more implantable housings along with a power source. 32. A method according to claim 1, wherein the selected pressure profile comprises a peak corresponding to the patient's cardiac activity. 33. A method according to claim 1, wherein the selected pressure profile comprises a peak corresponding to the patient's respiratory activity. 34. A method according to claim 1, wherein the selected pressure profile comprises a peak corresponding to the patient's cardiac activity and a peak corresponding to the patient's respiratory activity. 35. A method according to claim 12, wherein the method further includes determining if the pressure modulation profile includes pressure modulation caused by patient respiration by determining if the pressure modulation profile comprises a peak corresponding to the patient's respiratory activity.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (79)
Nakao Naomi L. (303 E. 57th St. New York NY 10022) Wilk Peter J. (185 W. End Ave. New York NY 10023) Mizzi John V. (30 Cramer Rd. ; R.F.D. #3 Poughkeepsie NY 12603), Anticlotting device and method for use with IV catheters.
Fischell Robert E. (Silver Spring MD), Apparatus for detecting a condition of a medication infusion system and providing an informational signal in response th.
Fischell Robert E. (Silver Spring MD), Apparatus for detecting at least one predetermined condition and providing an informational signal in response thereto i.
Pastrone Giovanni (Los Gatos CA) Johnson Noel L. (San Jose CA) Huang J. Terry (Sunnyvale CA) Allen Timothy (Mountain View CA), Automated drug infusion system with autopriming.
Michaels Mary B. (Sunnyvale CA) Robinson Janine C. (Half Moon Bay CA) Claude John P. (San Carlos CA) Alden Donald L. (Sunnyvale CA), Automated fluid pressure control system.
Natwick Vernon R. (Los Altos CA) Lawless Michael W. (Poway CA) Doll Joseph E. (Saratoga CA) Wu Chung-You C. (San Francisco CA), Detecting occlusion of proximal or distal lines of an IV pump.
Wojcicki Jan (Warsaw) Lilpop Boguslaw (Pruszhow) Ziembicki Marek (Warsaw) Bielawski Stanislaw (Warsaw PLX), Device for monitoring the operation of a delivery system and the method of use thereof.
Maeda Akihiro (Kyoto JPX) Kawahara Masafumi (Nara IL JPX) D\Silva Edmund D. (Highland Park IL) Kramer Larry (Chicago IL) Lynn Kenneth M. (McHenry IL), Display device for indicating the internal pressure of the tube of an infusion pump.
Voss Gregory I. (Solana Beach CA) Butterfield Robert D. (Poway CA) Baura Gail D. (San Diego CA) Barnes Casper W. (Murrieta CA), Fluid flow impedance monitoring system.
Halperin Louis E. (St. Paul MN) Lee Brian B. (Golden Valley MN) Roline Glenn M. (Anoka MN) Varrichio Anthony J. (Flanders NJ), Implantable capacitive absolute pressure and temperature monitor system.
Lord Peter C. (Valencia CA) Schultz John R. (Burbank CA) Powell David G. (South Pasadena CA), Implantable medication infusion pump including self-contained acoustic fault detection apparatus.
Bobo ; Jr. Donald E. (Orange CA) Meier Edward F. (Anaheim Hills CA) Seguine Dennis R. (Mission Viejo CA) Lapp Theodore R. (Mission Viejo CA), Infusion system, methodology, and algorithm for identifying patient-induced pressure artifacts.
Miki Fumio (Nara IL JPX) D\Silva Edmund D. (Highland Park IL) Esche Grace M. (Algonquin IL) Fairchild Michael S. (Lake Zurich IL) Kramer Larry (Chicago IL) Lynn Kenneth M. (McHenry IL), Liquid transfusion apparatus.
Gordon Timothy M. ; Scovill Stephen K. ; Fletcher-Haynes Peter ; Martin Scott, Method and apparatus for occlusion monitoring using pressure waveform analysis.
Sheldon B. Moberg ; James D. Causey, III ; Rex O. Bare ; Andrew J. Scherer ; Bradley J. Sargent, Methods, apparatuses, and uses for infusion pump fluid pressure and force detection.
Lebel, Ronald J.; Shahmirian, Varaz; Bowman, IV, Sam W.; Starkweather, Timothy J.; Morgan, Wayne A., Microprocessor controlled ambulatory medical apparatus with hand held communication device.
Shapiro, Philip; Davis-Reinhold, John; Warhurst, Julian; Hayes, Charles Daniel, System for monitoring and controlling pressure and concentration values in a fluid conduit.
Nowosielski Albert (Roselle IL) Mantell Robert (Arlington Heights IL) Manzie Peter (Berwyn IL) Zander Charles (Grayslake IL), Tubing system for delivering fluid to a surgical site.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.